Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Muley

Showing results (41-50 of 224) with videos related to

Pageof 23
Sort By:
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
A new bronchoscopic catheter for the transbronchial ablation of pulmonary nodulesSeyer Safi, Jan Op den Winkel, Steve Kramer, et al.
Journal of Surgical Oncology|March 28, 2025
Robot-Assisted Versus Open Surgery for the Resection of Large Thymomas: A Retrospective Cohort StudyBenedikt Niedermaier, Raffaella Griffo, Florian Eichhorn, et al.
Lung Cancer (Amsterdam, Netherlands)|April 25, 2008
A retrospective analysis of short and long-term survival after curative pulmonary resection for lung cancer in elderly patientsThomas Schneider, Joachim Pfannschmidt, Thomas Muley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 5, 2013
Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinomaBenedikte Jacobsen, Thomas Muley, Michael Meister, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patientsYoshikane Yamauchi, Seyer Safi, Thomas Muley, et al.
Cancer Cell International|February 6, 2026
Exploring the effects of tinzaparin and cisplatin on lung cancer cells in vitroJulia Held, Marc A Schneider, Beatriz Martinez-Delgado, et al.
Respiration; International Review of Thoracic Diseases|May 16, 2018
C-proSP-B: A Possible Biomarker for Pulmonary Diseases?Nicolas Kahn, Anne-Kathrin Rossler, Katrin Hornemann, et al.
Histopathology|January 25, 2014
ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 casesArne Warth, Thomas Muley, Hendrik Dienemann, et al.
Plos One|August 17, 2016
Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer PatientsSteffen Dietz, Uwe Schirmer, Clémentine Mercé, et al.
World Journal of Surgical Oncology|August 8, 2024
Peri- and postoperative morbidity and mortality in older patients with non-small cell lung cancer: a matched-pair studySeyer Safi, Maximilian Robert Gysan, Dorothea Weber, et al.
Pageof 23

Showing results (41-50 of 224) with videos related to

Sort By:
Pageof 23
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
A new bronchoscopic catheter for the transbronchial ablation of pulmonary nodulesSeyer Safi, Jan Op den Winkel, Steve Kramer, et al.
Journal of Surgical Oncology|March 28, 2025
Robot-Assisted Versus Open Surgery for the Resection of Large Thymomas: A Retrospective Cohort StudyBenedikt Niedermaier, Raffaella Griffo, Florian Eichhorn, et al.
Lung Cancer (Amsterdam, Netherlands)|April 25, 2008
A retrospective analysis of short and long-term survival after curative pulmonary resection for lung cancer in elderly patientsThomas Schneider, Joachim Pfannschmidt, Thomas Muley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 5, 2013
Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinomaBenedikte Jacobsen, Thomas Muley, Michael Meister, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patientsYoshikane Yamauchi, Seyer Safi, Thomas Muley, et al.
Cancer Cell International|February 6, 2026
Exploring the effects of tinzaparin and cisplatin on lung cancer cells in vitroJulia Held, Marc A Schneider, Beatriz Martinez-Delgado, et al.
Respiration; International Review of Thoracic Diseases|May 16, 2018
C-proSP-B: A Possible Biomarker for Pulmonary Diseases?Nicolas Kahn, Anne-Kathrin Rossler, Katrin Hornemann, et al.
Histopathology|January 25, 2014
ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 casesArne Warth, Thomas Muley, Hendrik Dienemann, et al.
Plos One|August 17, 2016
Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer PatientsSteffen Dietz, Uwe Schirmer, Clémentine Mercé, et al.
World Journal of Surgical Oncology|August 8, 2024
Peri- and postoperative morbidity and mortality in older patients with non-small cell lung cancer: a matched-pair studySeyer Safi, Maximilian Robert Gysan, Dorothea Weber, et al.
Pageof 23